Gardner Russo & Quinn’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $211K | Sell |
1,642
-499
| -23% | -$58.4K | ﹤0.01% | 83 |
|
|
2026
Q1 | $258K | Buy |
+2,141
| New | +$247K | ﹤0.01% | 82 |
|
|
2025
Q2 | – | Sell |
-2,763
| Closed | -$248K | – | 87 |
|
|
2025
Q1 | $248K | Sell |
2,763
-163
| -6% | -$15.2K | ﹤0.01% | 80 |
|
|
2024
Q4 | $291K | Sell |
2,926
-161
| -5% | -$16.6K | ﹤0.01% | 60 |
|
|
2024
Q3 | $351K | Sell |
3,087
-359
| -10% | -$42.7K | ﹤0.01% | 63 |
|
|
2024
Q2 | $427K | Sell |
3,446
-67
| -2% | -$8.63K | ﹤0.01% | 62 |
|
|
2024
Q1 | $464K | Sell |
3,513
-293
| -8% | -$36.1K | ﹤0.01% | 64 |
|
|
2023
Q4 | $415K | Sell |
3,806
-36
| -0.9% | -$3.74K | ﹤0.01% | 68 |
|
|
2023
Q3 | $396K | Sell |
3,842
-118
| -3% | -$12.7K | ﹤0.01% | 65 |
|
|
2023
Q2 | $457K | Buy |
3,960
+129
| +3% | +$14.6K | ﹤0.01% | 66 |
|
|
2023
Q1 | $408K | Buy |
3,831
+158
| +4% | +$17.1K | ﹤0.01% | 71 |
|
|
2022
Q4 | $408K | Sell |
3,673
-185
| -5% | -$18.9K | ﹤0.01% | 70 |
|
|
2022
Q3 | $332K | Sell |
3,858
-51
| -1% | -$4.55K | ﹤0.01% | 74 |
|
|
2022
Q2 | $356K | Buy |
3,909
+10
| +0.3% | +$887 | ﹤0.01% | 76 |
|
|
2022
Q1 | $320K | Buy |
3,899
+11
| +0.3% | +$867 | ﹤0.01% | 78 |
|
|
2021
Q4 | $298K | Buy |
3,888
+10
| +0.3% | +$796 | ﹤0.01% | 79 |
|
|
2021
Q3 | $291K | Buy |
3,878
+10
| +0.3% | +$761 | ﹤0.01% | 80 |
|
|
2021
Q2 | $301K | Sell |
3,868
-175
| -4% | -$13K | ﹤0.01% | 80 |
|
|
2021
Q1 | $297K | Sell |
4,043
-90
| -2% | -$6.64K | ﹤0.01% | 78 |
|
|
2020
Q4 | $323K | Buy |
4,133
+9
| +0.2% | +$688 | ﹤0.01% | 78 |
|
|
2020
Q3 | $326K | Buy |
4,124
+10
| +0.2% | +$783 | ﹤0.01% | 74 |
|
|
2020
Q2 | $304K | Buy |
4,114
+1,231
| +43% | +$92.7K | ﹤0.01% | 75 |
|
|
2020
Q1 | $212K | Hold |
2,883
| – | – | ﹤0.01% | 78 |
|
|
2019
Q4 | $250K | Sell |
2,883
-31
| -1% | -$2.55K | ﹤0.01% | 84 |
|
|
2019
Q3 | $234K | Hold |
2,914
| – | – | ﹤0.01% | 87 |
|
|
2019
Q2 | $233K | Sell |
2,914
-6
| -0.2% | -$459 | ﹤0.01% | 86 |
|
|
2019
Q1 | $232K | Hold |
2,920
| – | – | ﹤0.01% | 83 |
|
|
2018
Q4 | $213K | Buy |
+2,920
| New | +$206K | ﹤0.01% | 82 |
|
|
2018
Q1 | – | Sell |
-3,025
| Closed | -$162K | – | 139 |
|
|
2017
Q4 | $162K | Buy |
+3,025
| New | +$168K | ﹤0.01% | 108 |
|
|
2016
Q2 | – | Sell |
-4,020
| Closed | -$203K | – | 106 |
|
|
2016
Q1 | $203K | Hold |
4,020
| – | – | ﹤0.01% | 101 |
|
|
2015
Q4 | $203K | Buy |
+4,020
| New | +$203K | ﹤0.01% | 97 |
|
|
2015
Q3 | – | Sell |
-4,020
| Closed | -$218K | – | 106 |
|
|
2015
Q2 | $218K | Hold |
4,020
| – | – | ﹤0.01% | 95 |
|
|
2015
Q1 | $220K | Sell |
4,020
-524
| -12% | -$29.7K | ﹤0.01% | 98 |
|
|
2014
Q4 | $246K | Hold |
4,544
| – | – | ﹤0.01% | 94 |
|
|
2014
Q3 | $257K | Sell |
4,544
-53
| -1% | -$2.98K | ﹤0.01% | 99 |
|
|
2014
Q2 | $254K | Sell |
4,597
-157
| -3% | -$8.56K | ﹤0.01% | 102 |
|
|
2014
Q1 | $258K | Hold |
4,754
| – | – | ﹤0.01% | 102 |
|
|
2013
Q4 | $227K | Sell |
4,754
-1,257
| -21% | -$57.5K | ﹤0.01% | 102 |
|
|
2013
Q3 | $273K | Hold |
6,011
| – | – | ﹤0.01% | 100 |
|
|
2013
Q2 | $266K | Buy |
+6,011
| New | +$268K | ﹤0.01% | 99 |
|
Other funds holding MRK
Gardner Russo & Quinn's MRK Position: Q2 2026 in Review
Gardner Russo & Quinn reduced its Merck (MRK) stake by 23% in Q2 2026, selling an estimated $58.4K and leaving 1,642 shares worth $211K. The position accounts for ﹤0.01% of the portfolio, ranked #83.
Gardner Russo & Quinn first reported a position in MRK in Q2 2013 and has held it in 40 quarters since. The position peaked at $464K in Q1 2024. 3,818 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Gardner Russo & Quinn held 1,642 shares of Merck worth $211K as of Q2 2026.
- Gardner Russo & Quinn sold 499 Merck shares in Q2 2026, an estimated $58.4K.
- Merck made up ﹤0.01% of Gardner Russo & Quinn's portfolio in Q2 2026, its #83 holding.
- Gardner Russo & Quinn first reported a position in Merck in Q2 2013 and has held it in 40 quarters since.
- Gardner Russo & Quinn's Merck position peaked at $464K in Q1 2024.
- 3,818 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Gardner Russo & Quinn's 13F filing for Q2 2026, filed 13 Aug 2026.